Revisão sistemática | Agentes anti-interleucina-13 ou anti-interleucina-4 podem ser adequados para adultos com asma descontrolada moderada/grave que não responderam a outros tratamentos.

Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for people with asthma – Cochrane Library

Resumo: Anti-interleukin-13 or anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma – Cochrane Library

Comentário no Twitter (fio – clique para saber mais)

Lead author David Evans said “Approximately five to ten percent of people with asthma experience symptoms that are severe or difficult-to-treat… [1/3] pic.twitter.com/Nw606oSrX0

— CochraneAirways (@CochraneAirways) October 19, 2021